Quadrivio Group's Silver Economy Fund has acquired a 100% stake in MIR, a leading Italian company in the spirometry sector, to enhance its portfolio in the growing healthcare market focused on senior citizens.

Information on the Target

The target of this acquisition is MIR (Medical International Research), an Italian company founded in 1993 and a global leader in the spirometry sector, which focuses on lung function testing. Spirometry is the most frequently performed pulmonary function test and serves as a critical tool for monitoring patients, particularly those with asthma and chronic lung diseases, such as cystic fibrosis and primary ciliary dyskinesia. The need for innovative home spirometry services was underscored during the COVID-19 pandemic when traditional clinical visits became challenging, showcasing the importance of monitoring pulmonary function from home.

MIR operates from its headquarters in Rome, Italy, and has established branches in North America, France, and Brazil, supplemented by a robust distribution network that ensures its products reach over 100 countries. The company is internationally recognized for its unique patents and has developed an integrated diagnostic platform, offering medical devices such as pulse oximeters and spirometers, along with proprietary software that monitors vital health indicators in real-time.

Industry Overview in Italy

The healthcare industry in Italy has been undergoing significant transformation, especially in the wake of the COVID-19 pandemic. This period has accelerated the adoption of telehealth and home care services, p